Feasibility study of hospital antimicrobial stewardship analytics using electronic health records.
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
06
10
2020
accepted:
27
01
2021
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
Hospital antimicrobial stewardship (AMS) programmes are multidisciplinary initiatives to optimize antimicrobial use. Most hospitals depend on time-consuming manual audits to monitor clinicians' prescribing. But much of the information needed could be sourced from electronic health records (EHRs). To develop an informatics methodology to analyse characteristics of hospital AMS practice using routine electronic prescribing and laboratory records. Feasibility study using electronic prescribing, laboratory and clinical coding records from adult patients admitted to six specialities at Queen Elizabeth Hospital, Birmingham, UK (September 2017-August 2018). The study involved: (i) a review of AMS standards of care; (ii) their translation into concepts measurable from commonly available EHRs; and (iii) a pilot application in an EHR cohort study ( We developed data modelling methods to characterize antimicrobial use (antimicrobial therapy episode linkage methods, therapy table, therapy changes). Prescriptions were linked into antimicrobial therapy episodes (mean 2.4 prescriptions/episode; mean length of therapy 5.8 days), enabling several actionable findings. For example, 22% of therapy episodes for low-severity community-acquired pneumonia were congruent with prescribing guidelines, with a tendency to use broader-spectrum antibiotics. Analysis of therapy changes revealed IV to oral therapy switching was delayed by an average 3.6 days (95% CI: 3.4-3.7). Microbial cultures were performed prior to treatment initiation in just 22% of antibacterial prescriptions. The proposed methods enabled fine-grained monitoring of AMS practice down to specialities, wards and individual clinical teams by case mix, enabling more meaningful peer comparison. It is feasible to use hospital EHRs to construct rapid, meaningful measures of prescribing quality with potential to support quality improvement interventions (audit/feedback to prescribers), engagement with front-line clinicians on optimizing prescribing, and AMS impact evaluation studies.
Sections du résumé
BACKGROUND
BACKGROUND
Hospital antimicrobial stewardship (AMS) programmes are multidisciplinary initiatives to optimize antimicrobial use. Most hospitals depend on time-consuming manual audits to monitor clinicians' prescribing. But much of the information needed could be sourced from electronic health records (EHRs).
OBJECTIVES
OBJECTIVE
To develop an informatics methodology to analyse characteristics of hospital AMS practice using routine electronic prescribing and laboratory records.
METHODS
METHODS
Feasibility study using electronic prescribing, laboratory and clinical coding records from adult patients admitted to six specialities at Queen Elizabeth Hospital, Birmingham, UK (September 2017-August 2018). The study involved: (i) a review of AMS standards of care; (ii) their translation into concepts measurable from commonly available EHRs; and (iii) a pilot application in an EHR cohort study (
RESULTS
RESULTS
We developed data modelling methods to characterize antimicrobial use (antimicrobial therapy episode linkage methods, therapy table, therapy changes). Prescriptions were linked into antimicrobial therapy episodes (mean 2.4 prescriptions/episode; mean length of therapy 5.8 days), enabling several actionable findings. For example, 22% of therapy episodes for low-severity community-acquired pneumonia were congruent with prescribing guidelines, with a tendency to use broader-spectrum antibiotics. Analysis of therapy changes revealed IV to oral therapy switching was delayed by an average 3.6 days (95% CI: 3.4-3.7). Microbial cultures were performed prior to treatment initiation in just 22% of antibacterial prescriptions. The proposed methods enabled fine-grained monitoring of AMS practice down to specialities, wards and individual clinical teams by case mix, enabling more meaningful peer comparison.
CONCLUSIONS
CONCLUSIONS
It is feasible to use hospital EHRs to construct rapid, meaningful measures of prescribing quality with potential to support quality improvement interventions (audit/feedback to prescribers), engagement with front-line clinicians on optimizing prescribing, and AMS impact evaluation studies.
Identifiants
pubmed: 34223095
doi: 10.1093/jacamr/dlab018
pii: dlab018
pmc: PMC8210026
doi:
Types de publication
Journal Article
Langues
eng
Pagination
dlab018Subventions
Organisme : Medical Research Council
ID : MR/K006584/1
Pays : United Kingdom
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
Références
Arch Dis Child Educ Pract Ed. 2017 Aug 9;:
pubmed: 28794004
J Antimicrob Chemother. 2017 Jul 1;72(7):1880-1885
pubmed: 28369528
J R Soc Med. 2017 Aug;110(8):320-329
pubmed: 28730922
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Intensive Care Med. 2020 Feb;46(2):245-265
pubmed: 31781835
Antimicrob Resist Infect Control. 2019 Sep 13;8:151
pubmed: 31528337
Int J Med Inform. 2016 Aug;92:15-34
pubmed: 27318068
J Hosp Infect. 2019 Apr;101(4):426-427
pubmed: 30826342
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
J Antimicrob Chemother. 2015 Apr;70(4):1245-55
pubmed: 25527272
Ann Intern Med. 2016 Mar 15;164(6):435-41
pubmed: 26903136
Thorax. 2003 May;58(5):377-82
pubmed: 12728155
Clin Infect Dis. 2007 Jan 15;44(2):159-77
pubmed: 17173212
Expert Rev Clin Pharmacol. 2010 Sep;3(5):667-86
pubmed: 22111749
J Antimicrob Chemother. 2010 Mar;65(3):576-80
pubmed: 20053695
Int J Antimicrob Agents. 2007 Jun;29(6):693-9
pubmed: 17400430
Infect Dis Clin North Am. 2014 Jun;28(2):195-214
pubmed: 24857388
Clin Infect Dis. 2018 Jul 2;67(2):179-185
pubmed: 29409000
Virulence. 2013 Feb 15;4(2):151-7
pubmed: 23302793
J Antimicrob Chemother. 2017 Apr 1;72(4):1206-1216
pubmed: 27999065
Drugs. 2008;68(17):2469-81
pubmed: 19016574
BMJ. 2000 Mar 18;320(7237):750-3
pubmed: 10720357
Clin Microbiol Infect. 2019 Jan;25(1):20-25
pubmed: 29625170
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
PLoS One. 2017 Aug 24;12(8):e0183062
pubmed: 28837665
Stud Health Technol Inform. 2008;136:641-6
pubmed: 18487803